Disinfection by-products and ecotoxic risk associated with hypochlorite treatment of irbesartan.
Acute toxicity test
Chlorination
Daphnia magna
Disinfection by-products
Disinfection treatments
Irbesartan
Journal
The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500
Informations de publication
Date de publication:
10 Apr 2020
10 Apr 2020
Historique:
received:
05
09
2019
revised:
14
11
2019
accepted:
17
11
2019
entrez:
14
2
2020
pubmed:
14
2
2020
medline:
23
4
2020
Statut:
ppublish
Résumé
Recently, many studies highlighted the consistent finding of irbesartan in effluents from wastewater treatment plants (WWTPs) and in some rivers and lakes in both Europe and North America, suggesting that no >80% can be removed by specific treatments. The present investigation attempts to study the chemical fate of irbesartan in a simulated chlorination step, mimicking the conditions of a WWTP. A total of six disinfection by-products were identified, five were completely new, and separated on a C-18 column by employing a gradient HPLC method. Initially, a complete mass fragmentation pathway of the drug was established with the help of MS/TOF, and subsequently, the disinfection by-products were subjected to MS/TOF mass studies to obtain their mass and fragment pattern. The MS results helped to assign tentative structures to the disinfection products, which were verified through 1D and 2D NMR experiments. The chemical structures of the new compounds have been justified by a proposed mechanism of formation. A preliminary ecotoxicity assessment with the crustacean Daphnia magna showed that some of the identified by-products were up to 12-times more toxic than irbesartan.
Identifiants
pubmed: 32050394
pii: S0048-9697(19)35620-7
doi: 10.1016/j.scitotenv.2019.135625
pii:
doi:
Substances chimiques
Water Pollutants, Chemical
0
Hypochlorous Acid
712K4CDC10
Irbesartan
J0E2756Z7N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
135625Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no conflict of interest to declare.